Metabolic Model Service Provider Comparison
The four archetypes
| Archetype | Strength | Structural limit |
|---|---|---|
| Academic core facility | Deep method expertise; instrument access; publication track record | Queue-based scheduling; limited model building; variable documentation |
| Assay-only CRO | Throughput, turnaround, price | You supply the model, and the model is usually the hard part |
| Full-chain provider | Model, assay and tracing under one quality system | Higher cost; less flexibility on bespoke readouts |
| In-house | Control, iteration speed, IP | Capital, headcount, and the maintenance burden of instruments |
Important distinction. These are not quality tiers. A core facility with a decade of ¹³C experience will outperform a full-chain provider on a difficult tracing question, and a full-chain provider will outperform it on a project that needs a knockout line, a validated assay and a report in one package.
Eight dimensions
| Dimension | What to ask | Why it decides the project |
|---|---|---|
| Model building | Can you make the genetic model, or only assay it? | The model is where most timelines are lost |
| Assay menu | Which flux assays, on which sample types? | A menu without spheroids or suspension cells is a partial menu |
| Tracing | Tracers, platforms, positional resolution | Determines whether a mechanism question is answerable |
| Data analysis | Raw data, derived parameters, assumptions | Without assumptions the result cannot be re-analysed |
| QC documentation | Which controls are reported by default | Distinguishes a measurement from a number |
| Turnaround | Quoted in working days, with dependencies | Model building and assay time are different clocks |
| Batch flexibility | Minimum batch, ability to add arms | Retrospective arms are the commonest hidden cost |
| Technology transfer | Protocols, cell banks, instrument files | Determines whether you can leave |
The fourth row separates providers more than price does. A report that gives only derived values cannot be re-examined when a reviewer asks about normalisation.
Six scenarios
| Your situation | Recommended | Reason |
|---|---|---|
| You have the model, need one assay, need it this month | Assay-only CRO or core | No model-building overhead |
| You need a knockout line and a validated phenotype package | Full-chain | Handoffs between vendors cost more than the price difference |
| You have a difficult tracing question | Academic core or specialist | Depth beats breadth here |
| You have the instruments and one expert | In-house, with external QC | Keeps iteration speed; the external check protects against drift |
| You need a screening campaign with follow-up | Full-chain, staged | Staging protects you from paying for the follow-up before the hits exist |
| You need a model your field does not have yet | Collaborative development | Neither a menu nor a quote fits a method that does not exist |
When the answer is not us
- • You need behavioural or physiological phenotyping in animals. We do not run it, and a provider who claims the full chain usually subcontracts this part.
- • You need clinical cohort data or patient samples. That is a different supply chain with different ethics and consent requirements.
- • You need a single assay this week and you already have the model. Our onboarding takes longer than your deadline; a local core is the right call, and we will say so.
Publishing this list is not altruism. A comparison page that never recommends a competitor is read as advertising, and it should be.
RFQ: eight specifications to request
- Which steps are performed on site, and which are subcontracted.
- The QC controls included by default, and the ones that cost extra.
- Whether raw instrument files are delivered.
- The normalisation method used, and whether it can be changed.
- The number of biological replicates included, and the definition of a replicate.
- The failure policy: what happens if the assay fails QC, and who pays.
- The turnaround quoted in working days, with the dependencies named.
- The transfer package: cell banks, vectors, protocols, analysis scripts.
Items 3, 5 and 6 are the ones that most often change the total cost after the quote is signed.
What we do not promise
- • The lowest price. A quote that omits the model-building step is not comparable with one that includes it.
- • A phenotype. Assays report rates; whether the pathway matters is the biological question.
- • A single vendor for everything. Where a step is better done elsewhere, we say so in the quote.
Where this connects
- • The other pages in this group describe the specific services being compared: reporter lines, knockout lines, phenotyping and tracing.
- • The self-assessment should be completed before an RFQ; a design with a low readout score will not be fixed by choosing a different provider.
Selected references for further reading
- • Divakaruni AS, Jastroch M. A practical guide for the analysis, standardization and interpretation of oxygen consumption measurements. Nature Metabolism. 2022;4:978–994.
- • Jang C, Chen L, Rabinowitz JD. Metabolomics and isotope tracing. Cell. 2018;173:822–837.
- • Begley CG, Ioannidis JPA. Reproducibility in science: improving the standard for basic and preclinical research. Circulation Research. 2015;116:116–126.
Related Services
Related Products
| Product name | Cat.No. | Species | Gene ID | |
|---|---|---|---|---|
| PBRM1 Knockout A-549 Cell Line | EDJ0001-K01 | Human | 55193 | Details Get a Quote |
| YTHDC1 Knockout A-549 Cell Line | EDC07652 | Human | 91746 | Details Get a Quote |
| TP53 Knockout HCT 116 Cell Line | EDC07854 | Human | 7157 | Details Get a Quote |
| Sirt2 Knockout MH-S Cell Line | EDJ-KQ78173 | Mouse | 64383 | Details Get a Quote |
| TFE3 Knockout KGN Cell Line | EDJ-KQ48 | Human | 7030 | Details Get a Quote |
| Stub1 Knockout MB49 Cell Line | EDJ-KQ53 | Mouse | 56424 | Details Get a Quote |
| ARID1A Knockout SNK-6 Cell Line | EDJ-KQ64 | Human | 8289 | Details Get a Quote |
| Tet1 Knockout Kupffer Cell Line | EDJ-KQ88 | Mouse | 52463 | Details Get a Quote |
| NR1H3 Knockout HEK293T Cell Line | EDJ-KQ109 | Human | 10062 | Details Get a Quote |
| NR1H2 Knockout HEK293T Cell Line | EDJ-KQ110 | Human | 7376 | Details Get a Quote |
| RPS6KB2 Knockout HEK293 Cell Line | EDJ-KQ125 | Human | 6199 | Details Get a Quote |
| SMAD6 Knockout HEK293 Cell Line | EDJ-KQ126 | Human | 4091 | Details Get a Quote |
| JUN Knockout HEK293 Cell Line | EDJ-KQ176 | Human | 3725 | Details Get a Quote |
| JUN Knockout HEK293T Cell Line | EDJ-KQ184 | Human | 3725 | Details Get a Quote |
| ALKBH5 Knockout HEK293 Cell Line | EDJ-KQ186 | Human | 54890 | Details Get a Quote |
- 1
- 2
- ...
- Next Page »